Skip to main content

Daniel A. Waizman, PhD

Daniel A. Waizman, PhD

Project title
"IL25 induced tissue resilience in the prevention of colorectal cancer and therapy-induced adverse events"

Dr. Waizman [Connie and Bob Lurie Fellow] is trying to understand how we can apply principles of resilience in the context of colorectal cancer. He is investigating how a cellular alarm signal known as Interleukin-25 triggers the immune system to create protective layers within barrier tissues, such as the intestine, to increase their environmental defenses and capacity for tissue regeneration after injury. These layers could serve two-fold functions–in prevention of colorectal cancer and the prevention or reduction of adverse side effects of cancer treatment, which serve as a barrier to continued treatment. Dr. Waizman received his PhD from Yale University, New Haven, and his BA from Cornell University, Ithaca.

Institution
University of California, San Francisco
Sponsor(s) / Mentor(s)
Ari B. Molofsky, MD, PhD, and Richard M. Locksley, MD
Cancer type
Colorectal
Research area
Prevention
Award Program
Fellow
Named Award
Connie and Bob Lurie Fellow